Cargando…

Randomized trial of vilazodone versus sertraline in depression: Concerns and comments

Detalles Bibliográficos
Autor principal:	Praharaj, Samir Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265422/ https://www.ncbi.nlm.nih.gov/pubmed/34100405 http://dx.doi.org/10.4103/ijp.IJP_288_20

Ejemplares similares

A 12-week prospective randomized controlled comparative trial of vilazodone and sertraline in Indian patients with depression
por: Bathla, Manish, et al.
Publicado: (2020)

An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2022)

Vilazodone-Induced Hyperglycemia: A Case Series
por: Das, Abhipsa, et al.
Publicado: (2020)

Vilazodone for the Treatment of Depression: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

How prevalent are depression and anxiety symptoms in hypothyroidism?
por: Praharaj, Samir Kumar
Publicado: (2016)

Overestimation of Depression Prevalence among Adolescent Students
por: Praharaj, Samir Kumar
Publicado: (2017)

Repetitive Transcranial Magnetic Stimulation in Depression: Studies from India
por: Praharaj, Samir Kumar
Publicado: (2011)

Pain threshold and pain tolerance as a predictor of deliberate self-harm among adolescents and young adults: Concerns regarding methodology
por: Vishwanath, Rashmi, et al.
Publicado: (2022)

Delirium associated with discontinuation of sertraline in an elderly
por: Das, Subhash, et al.
Publicado: (2019)

Unmodified electroconvulsive therapy: Concerns about reporting in a retrospective study
por: Andrade, Chittaranjan, et al.
Publicado: (2017)

A Review of Vilazodone, Serotonin, and Major Depressive Disorder
por: Pierz, Kerri A., et al.
Publicado: (2014)

Prolonged sertraline use related carcinoembryonic antigen increase
por: Ceylan, Mehmet Emin, et al.
Publicado: (2021)

SERTRALINE AND BUSPIRONE IN ADOLESCENT DELUSIONAL BODY DYSMORPHIC DISORDER
por: Duggal, Harpreet S., et al.
Publicado: (2001)

Serotonin syndrome associated with sertraline, trazodone and tramadol abuse
por: Nayyar, Neha
Publicado: (2009)

Hyperamylasemia Related to Sertraline
por: Ceylan, Mehmet Emin, et al.
Publicado: (2016)

Arthroscopic management of popliteal cyst: Comments and concerns
por: Vaishya, Raju, et al.
Publicado: (2017)

Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2014)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
por: Sahli, Zeyad T., et al.
Publicado: (2016)

Lithium not only stabilizes mood, it is also neuroprotective
por: Praharaj, Samir Kumar
Publicado: (2011)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia?
por: Praharaj, Samir Kumar
Publicado: (2011)

Abuse Liability of Baclofen
por: Praharaj, Samir Kumar
Publicado: (2018)

Clozapine Use in Adolescents
por: Praharaj, Samir Kumar
Publicado: (2017)

Bupropion and Iron for Restless Leg Syndrome: Do They Have Efficacy Similar to Ropinirole?
por: Praharaj, Samir Kumar
Publicado: (2017)

Commentary on “high-risk behavior in patients with alcohol dependence”
por: Praharaj, Samir Kumar
Publicado: (2019)

A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder
por: Sinha, Shubhadeep, et al.
Publicado: (2021)

Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials
por: Shi, Ligen, et al.
Publicado: (2016)

Development of Restless Leg Syndrome in a Pediatric Patient Treated with Sertraline
por: Majumder, Pradipta
Publicado: (2020)

Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
por: Khan, Arif, et al.
Publicado: (2014)

Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
por: Durgam, Suresh, et al.
Publicado: (2018)

Problems in using WhatsApp groups for survey research
por: Ameen, Shahul, et al.
Publicado: (2020)

High density lipoprotein: State marker for dependence status of Mahua
por: Singh, Lokesh Kumar, et al.
Publicado: (2011)

Approval from the ethics committee in published studies from the Indian Journal of Psychiatry
por: Praharaj, Samir Kumar, et al.
Publicado: (2023)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
por: Mathews, Maju, et al.
Publicado: (2015)

Comment on: Intracorporeal Versus Extracorporeal Anastomosis in Robotic Right Colectomy: A Multicenter, Triple-Blind, Randomized Clinical Trial
por: Meyer, Jeremy, et al.
Publicado: (2023)

Comments on: Academic quality of incoming ophthalmology residents in India: Concerns for the future
por: Gurnani, Bharat, et al.
Publicado: (2021)

Comment on: “Hepatitis C Virus in Arab World: A State of Concern”
por: Gasim, Gasim I.
Publicado: (2012)

Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice
por: Chauhan, Mohit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_54encfl5j693c6grhdkr632prc